Estimating tumor purity from single samples
AssigneePersonalis, Inc.
InventorsNicholas Phillips, Jason Harris
Life of this patent
Estimating the term…
Loading patent…
AssigneePersonalis, Inc.
InventorsNicholas Phillips, Jason Harris
Estimating the term…
The disclosure provides methods for estimating tumor purity from tumor samples without use of matched-normal controls. A set of genomic regions are identified based on a nucleic acid sequence data that is aligned to a reference genome. Each genomic region of the set of genomic regions includes one or more nucleotide-sequence variants relative to a corresponding genomic region of the reference genome. A B-allele frequency distribution for the biological sample is determined based on a B-allele frequency determined for each genomic region of the set of genomic regions. The B-allele frequency distribution is processed using a trained machine-learning model to estimate a metric identifying tumor purity in the biological sample.
A method of determining tumor purity of a biological sample of a subject for informing a cancer feature and evaluating a treatment efficacy for the subject, the method comprising:
A system comprising:
Dependencies are inferred from the claim text.